COLGATE-PALMOLIVE CO

Colgate‑Palmolive insiders surge in buying: CEO, COO and CFO acquire thousands of shares and options, signaling confidence amid inflation pressures.

Colgate‑Palmolive CFO’s 1,197‑share sale amid a portfolio review shows routine tax‑vesting moves, not a warning sign.

Colgate‑Palmolive insider sale: COO sells 10k shares at $92.05—routine liquidity, not a red flag. Investor outlook remains positive amid steady buying and selling trends.

Colgate‑Palmolive insider trades show short‑term profit on options, hinting at a possible rally but no major shift in fundamentals.

Colgate‑Palmolive insider buying shows strong confidence—executive purchases of 70k+ shares at $88, amid solid liquidity and a $67.9 billion market cap, indicating potential upside.

Colgate‑Palmolive insiders buy shares amid modest price rise; their actions suggest confidence in the firm’s long‑term value and potential upside.

Colgate‑Palmolive insider activity shows execs buying zero‑cost shares while locking gains, confirming AI and pet‑nutrition moves are driving growth.

Colgate‑Palmolive insider activity: COO Tsourapas buys 35,000 shares and sells high‑priced options, signaling short‑term bullish confidence near the 52‑week high.